M. Angela Cenci

Publications

• Reply To: Letter to Editor by Chaudhuri, Jenner, Antonini
  Movement Disorders : Official Journal of the Movement Disorder Society. May, 2020  |   Pubmed ID: 32415716
• Preface: The Evolving Scenario of Parkinson's Research
  Progress in Brain Research. 2020  |   Pubmed ID: 32247377
• Animal Models for Preclinical Parkinson's Research: An Update and Critical Appraisal
  Progress in Brain Research. 2020  |   Pubmed ID: 32247366
• The Role of Glia in Parkinson's Disease: Emerging Concepts and Therapeutic Applications
  Progress in Brain Research. 2020  |   Pubmed ID: 32247363
• D1-mGlu5 Heteromers Mediate Noncanonical Dopamine Signaling in Parkinson's Disease
  The Journal of Clinical Investigation. Mar, 2020  |   Pubmed ID: 32039920
• Dyskinesia Matters
  Movement Disorders : Official Journal of the Movement Disorder Society. Mar, 2020  |   Pubmed ID: 31872501
• Seeding of Protein Aggregation Causes Cognitive Impairment in Rat Model of Cortical Synucleinopathy
  Movement Disorders : Official Journal of the Movement Disorder Society. 11, 2019  |   Pubmed ID: 31449702
• Pridopidine Induces Functional Neurorestoration Via the Sigma-1 Receptor in a Mouse Model of Parkinson's Disease
  Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics. 04, 2019  |   Pubmed ID: 30756361
• Significance and Translational Value of High-Frequency Cortico-Basal Ganglia Oscillations in Parkinson's Disease
  Journal of Parkinson's Disease. 2019  |   Pubmed ID: 30594935
• Striatonigral Neurons Divide into Two Distinct Morphological-physiological Phenotypes After Chronic L-DOPA Treatment in Parkinsonian Rats
  Scientific Reports. 07, 2018  |   Pubmed ID: 29968767
• On the Neuronal Circuitry Mediating L-DOPA-induced Dyskinesia
  Journal of Neural Transmission (Vienna, Austria : 1996). 08, 2018  |   Pubmed ID: 29704061
• MGlu Receptors in the Treatment of Parkinson's Disease and L-DOPA-induced Dyskinesia
  Current Opinion in Pharmacology. 02, 2018  |   Pubmed ID: 29625424
• Animal Models of L-dopa-induced Dyskinesia in Parkinson's Disease
  Movement Disorders : Official Journal of the Movement Disorder Society. 07, 2018  |   Pubmed ID: 29488257
• Levodopa-induced Abnormal Involuntary Movements Correlate with Altered Permeability of the Blood-brain-barrier in the Basal Ganglia
  Scientific Reports. 11, 2017  |   Pubmed ID: 29167476
• Translating Scientific Advances into Disease-modifying Therapies for Parkinson's Disease
  Experimental Neurology. 12, 2017  |   Pubmed ID: 29145992
• CK2 Oppositely Modulates L-DOPA-Induced Dyskinesia Via Striatal Projection Neurons Expressing D1 or D2 Receptors
  The Journal of Neuroscience : the Official Journal of the Society for Neuroscience. 12, 2017  |   Pubmed ID: 29097596
• Neuroprotection and Neurorestoration As Experimental Therapeutics for Parkinson's Disease
  Experimental Neurology. 12, 2017  |   Pubmed ID: 28988910
• Differential Effects of Gaseous Versus Injectable Anesthetics on Changes in Regional Cerebral Blood Flow and Metabolism Induced by L-DOPA in a Rat Model of Parkinson's Disease
  Experimental Neurology. 06, 2017  |   Pubmed ID: 28284817
• Validation of an Improved Scale for Rating L-DOPA-induced Dyskinesia in the Mouse and Effects of Specific Dopamine Receptor Antagonists
  Neurobiology of Disease. Dec, 2016  |   Pubmed ID: 27597526
• Dissociation of Metabolic and Hemodynamic Levodopa Responses in the 6-hydroxydopamine Rat Model
  Neurobiology of Disease. Dec, 2016  |   Pubmed ID: 27544483
• Dramatic Differences in Susceptibility to L-DOPA-induced Dyskinesia Between Mice That Are Aged Before or After a Nigrostriatal Dopamine Lesion
  Neurobiology of Disease. Oct, 2016  |   Pubmed ID: 27312773
• Gene Therapy Blockade of Dorsal Striatal P11 Improves Motor Function and Dyskinesia in Parkinsonian Mice
  Proceedings of the National Academy of Sciences of the United States of America. Feb, 2016  |   Pubmed ID: 26787858
• On the Effect of Eltoprazine in Dyskinetic Hemiparkinsonian Rats
  Movement Disorders : Official Journal of the Movement Disorder Society. Jan, 2016  |   Pubmed ID: 26749366
• M4 Muscarinic Receptor Signaling Ameliorates Striatal Plasticity Deficits in Models of L-DOPA-Induced Dyskinesia
  Neuron. Nov, 2015  |   Pubmed ID: 26590347
• Increased CSF Biomarkers of Angiogenesis in Parkinson Disease
  Neurology. Nov, 2015  |   Pubmed ID: 26511451
• Rodent Models of Impulsive-compulsive Behaviors in Parkinson's Disease: How Far Have We Reached?
  Neurobiology of Disease. Oct, 2015  |   Pubmed ID: 26325219
• Zooming in on the Small: the Plasticity of Striatal Dendritic Spines in L-DOPA-induced Dyskinesia
  Movement Disorders : Official Journal of the Movement Disorder Society. Apr, 2015  |   Pubmed ID: 25759263
• Pharmacological Stimulation of Metabotropic Glutamate Receptor Type 4 in a Rat Model of Parkinson's Disease and L-DOPA-induced Dyskinesia: Comparison Between a Positive Allosteric Modulator and an Orthosteric Agonist
  Neuropharmacology. Aug, 2015  |   Pubmed ID: 25749357
• Activity of Serotonin 5-HT(1A) Receptor 'biased Agonists' in Rat Models of Parkinson's Disease and L-DOPA-induced Dyskinesia
  Neuropharmacology. Jun, 2015  |   Pubmed ID: 25645393
• A Genetic Mouse Model of Parkinson's Disease Shows Involuntary Movements and Increased Postsynaptic Sensitivity to Apomorphine
  Molecular Neurobiology. Dec, 2015  |   Pubmed ID: 25307288
• Presynaptic Mechanisms of L-DOPA-Induced Dyskinesia: The Findings, the Debate, and the Therapeutic Implications
  Frontiers in Neurology. 2014  |   Pubmed ID: 25566170
• Cell Type-specific Plasticity of Striatal Projection Neurons in Parkinsonism and L-DOPA-induced Dyskinesia
  Nature Communications. Oct, 2014  |   Pubmed ID: 25360704
• Pharmacological Stimulation of Sigma-1 Receptors Has Neurorestorative Effects in Experimental Parkinsonism
  Brain : a Journal of Neurology. Jul, 2014  |   Pubmed ID: 24755275
• Mechanisms of Dopamine D1 Receptor-mediated ERK1/2 Activation in the Parkinsonian Striatum and Their Modulation by Metabotropic Glutamate Receptor Type 5
  The Journal of Neuroscience : the Official Journal of the Society for Neuroscience. Mar, 2014  |   Pubmed ID: 24672017
• Glutamatergic Pathways As a Target for the Treatment of Dyskinesias in Parkinson's Disease
  Biochemical Society Transactions. Apr, 2014  |   Pubmed ID: 24646284
• Molecular Adaptations of Striatal Spiny Projection Neurons During Levodopa-induced Dyskinesia
  Proceedings of the National Academy of Sciences of the United States of America. Mar, 2014  |   Pubmed ID: 24599591
• Investigating the Molecular Mechanisms of L-DOPA-induced Dyskinesia in the Mouse
  Parkinsonism & Related Disorders. Jan, 2014  |   Pubmed ID: 24262181
• Region-specific Restoration of Striatal Synaptic Plasticity by Dopamine Grafts in Experimental Parkinsonism
  Proceedings of the National Academy of Sciences of the United States of America. Nov, 2013  |   Pubmed ID: 24170862
• Modulating MGluR5 and 5-HT1A/1B Receptors to Treat L-DOPA-induced Dyskinesia: Effects of Combined Treatment and Possible Mechanisms of Action
  Experimental Neurology. Dec, 2013  |   Pubmed ID: 24029003
• Bad News for Neuroprotective Therapies in PD?
  Journal of Parkinson's Disease. Jan, 2013  |   Pubmed ID: 24018335
• A Model of GDNF Gene Therapy in Mice with 6-Hydroxydopamine Lesions: Time Course of Neurorestorative Effects and ERK1/2 Activation
  Journal of Parkinson's Disease. 2012  |   Pubmed ID: 23938263
• Levodopa-induced Dyskinesia is Strongly Associated with Resonant Cortical Oscillations
  The Journal of Neuroscience : the Official Journal of the Society for Neuroscience. Nov, 2012  |   Pubmed ID: 23175810
• Impact of L-DOPA Treatment on Regional Cerebral Blood Flow and Metabolism in the Basal Ganglia in a Rat Model of Parkinson's Disease
  NeuroImage. May, 2012  |   Pubmed ID: 22406356
• Current Options and Future Possibilities for the Treatment of Dyskinesia and Motor Fluctuations in Parkinson's Disease
  CNS & Neurological Disorders Drug Targets. Sep, 2011  |   Pubmed ID: 21838677
• Vascular Endothelial Growth Factor is Upregulated by L-dopa in the Parkinsonian Brain: Implications for the Development of Dyskinesia
  Brain : a Journal of Neurology. Aug, 2011  |   Pubmed ID: 21771855
• Impact of the Lesion Procedure on the Profiles of Motor Impairment and Molecular Responsiveness to L-DOPA in the 6-hydroxydopamine Mouse Model of Parkinson's Disease
  Neurobiology of Disease. Jun, 2011  |   Pubmed ID: 21310234
• Inhibition of Ras-guanine Nucleotide-releasing Factor 1 (Ras-GRF1) Signaling in the Striatum Reverts Motor Symptoms Associated with L-dopa-induced Dyskinesia
  Proceedings of the National Academy of Sciences of the United States of America. Dec, 2010  |   Pubmed ID: 21115823
• Maladaptive Plasticity of Serotonin Axon Terminals in Levodopa-induced Dyskinesia
  Annals of Neurology. Nov, 2010  |   Pubmed ID: 20882603
• Maladaptive Striatal Plasticity in L-DOPA-induced Dyskinesia
  Progress in Brain Research. 2010  |   Pubmed ID: 20696322
• A MGluR5 Antagonist Under Clinical Development Improves L-DOPA-induced Dyskinesia in Parkinsonian Rats and Monkeys
  Neurobiology of Disease. Sep, 2010  |   Pubmed ID: 20452425
• L-DOPA-induced Dopamine Efflux in the Striatum and the Substantia Nigra in a Rat Model of Parkinson's Disease: Temporal and Quantitative Relationship to the Expression of Dyskinesia
  Journal of Neurochemistry. Mar, 2010  |   Pubmed ID: 20050978
• Rodent Models of Treatment-induced Motor Complications in Parkinson's Disease
  Parkinsonism & Related Disorders. Dec, 2009  |   Pubmed ID: 20123549
• Plastic Effects of L-DOPA Treatment in the Basal Ganglia and Their Relevance to the Development of Dyskinesia
  Parkinsonism & Related Disorders. Dec, 2009  |   Pubmed ID: 20083009
• Differential Involvement of D1 and D2 Dopamine Receptors in L-DOPA-induced Angiogenic Activity in a Rat Model of Parkinson's Disease
  Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. Nov, 2009  |   Pubmed ID: 19606087
• Pharmacological Modulation of Glutamate Transmission in a Rat Model of L-DOPA-induced Dyskinesia: Effects on Motor Behavior and Striatal Nuclear Signaling
  The Journal of Pharmacology and Experimental Therapeutics. Jul, 2009  |   Pubmed ID: 19357321
• Ratings of L-DOPA-induced Dyskinesia in the Unilateral 6-OHDA Lesion Model of Parkinson's Disease in Rats and Mice
  Current Protocols in Neuroscience. Oct, 2007  |   Pubmed ID: 18428668
• L-DOPA-induced Dyskinesia: Cellular Mechanisms and Approaches to Treatment
  Parkinsonism & Related Disorders. 2007  |   Pubmed ID: 18267248
• Spatiotemporal Pattern of Striatal ERK1/2 Phosphorylation in a Rat Model of L-DOPA-induced Dyskinesia and the Role of Dopamine D1 Receptors
  Biological Psychiatry. Oct, 2007  |   Pubmed ID: 17662258
• Dopamine Dysregulation of Movement Control in L-DOPA-induced Dyskinesia
  Trends in Neurosciences. May, 2007  |   Pubmed ID: 17400300
• Antagonism of Metabotropic Glutamate Receptor Type 5 Attenuates L-DOPA-induced Dyskinesia and Its Molecular and Neurochemical Correlates in a Rat Model of Parkinson's Disease
  Journal of Neurochemistry. Apr, 2007  |   Pubmed ID: 17359492
• The "motor Complication Syndrome" in Rats with 6-OHDA Lesions Treated Chronically with L-DOPA: Relation to Dose and Route of Administration
  Behavioural Brain Research. Feb, 2007  |   Pubmed ID: 17157933
• Endothelial Proliferation and Increased Blood-brain Barrier Permeability in the Basal Ganglia in a Rat Model of 3,4-dihydroxyphenyl-L-alanine-induced Dyskinesia
  The Journal of Neuroscience : the Official Journal of the Society for Neuroscience. Sep, 2006  |   Pubmed ID: 16971529
• Post- Versus Presynaptic Plasticity in L-DOPA-induced Dyskinesia
  Journal of Neurochemistry. Oct, 2006  |   Pubmed ID: 16942598
• Graft Placement and Uneven Pattern of Reinnervation in the Striatum is Important for Development of Graft-induced Dyskinesia
  Neurobiology of Disease. Mar, 2006  |   Pubmed ID: 16256359
• Dyskinesias and Dopamine Cell Replacement in Parkinson's Disease: a Clinical Perspective
  Brain Research Bulletin. Dec, 2005  |   Pubmed ID: 16324999
• L-DOPA-induced Dyskinesia in the Intrastriatal 6-hydroxydopamine Model of Parkinson's Disease: Relation to Motor and Cellular Parameters of Nigrostriatal Function
  Neurobiology of Disease. Jul, 2002  |   Pubmed ID: 12127155
• Pharmacological Validation of Behavioural Measures of Akinesia and Dyskinesia in a Rat Model of Parkinson's Disease
  The European Journal of Neuroscience. Jan, 2002  |   Pubmed ID: 11860512
• CAMP Response Element-binding Protein is Required for Dopamine-dependent Gene Expression in the Intact but Not the Dopamine-denervated Striatum
  The Journal of Neuroscience : the Official Journal of the Society for Neuroscience. Dec, 2001  |   Pubmed ID: 11739600